TrialNature medicine2023

RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts.

Gerald F Watts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.